Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Mellow Hope Pharm Industrial Co., Ltd. is a prominent Chinese biopharmaceutical company focused on the research, development, and international distribution of vaccines and blood products. Established in 2002 and headquartered in Xi'an, the company serves as a critical bridge for Chinese biological products entering global markets, including Southeast Asia, Africa, and Latin America. Their extensive commercial portfolio features vaccines for Hepatitis A, Hepatitis B, Influenza, and Rabies, alongside various human albumin and immunoglobulin products. Mellow Hope is recognized for its expertise in navigating international regulatory frameworks and maintaining robust cold-chain logistics for sensitive biopharmaceuticals. The company also engages in the distribution of medical devices and provides consulting services for clinical trials and product registration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mellow Hope.